Manifestation of vasculitis and HN is now being increasingly being observed
. However, clinicians need to be conscious of the possible direct associati
on of this virus with vascular disease. It would appear that the nervous an
d musculoskeletal systems are most commonly affected. No systematic data ex
ist on the benefit of pharmacological agents currently used and there is an
axiomatic need to study these agents in terms of the risk/benefit.